particles became available, a series of conferences was held in Berkeley to consider whether these highly penetrating particles (which had less scatter than conventional roentgen and gamma radiation) should be used in external therapy for patients with various types of cancer. It was concluded that they did not offer enough, from the standpoint of phy ics and dosimetry, to justify an effort to apply them in the treatment of patients with such tumors as those of the brain, lung, and abdomen. However, experiments on animals did reveal that, by using a high-energy beam of these particles, such as the 900-million volt alpha particles or protons from the synchrocyclotron, it was possible to produce localized destructive lesions in animals (TOBIAS et colI. 1952) .
In view of the clinical developments where surgical hypophysectomy was being carried out for the treatment of patients with acromegaly, advanced whether they be normal or neoplastic. Although we have used the Bragg curve with rotation in many of the studies (TOBIAS et colI. 1952 , LAWRENCE et colI. 1962 , in this paper we are reporting the head rotation technique described previously (LAWRENCE & TOBIAS 1956 , LAWRENCE 1957 , TOBIAS et colI. 1958 .
With the use of the Bragg curve and rotation it has been possible to deliver even greater doses to selected tissues compared to the other tissues. In this series of patients with acromegaly, there are 11 males and 6 females ( Table 1) . The onset of their symptoms varied from ages 15 to 52 years, with an average age of onset at 30 years. The age at which pituitary irradiation was started varied from 17 to 59, with an average of 40 years. One of the patients had cardiovascular disease with a blood pressure of 230/145; the others had normal blood pressures. Two had associated diabetes mellitus, 4 arthritis, 2 gastric ulcer, one had cardiovascular disease, and 2 had psychiatric episodes.
Of the 17 patients, the symptom of lethargy and weakness was present in 14, excess perspiration in 13, headache in 15, enlargement of hands and feet in 16, and of tongue in 15. Other symptoms were: polydypsia, polyuria, and 3 0 polyphagia in 5, decreased libido in 6 out of 12 questioned, visual symptoms and signs in 6 out of 17, change in speech in 6, widening of the spaces between the teeth in 6, and dentures in 6. The sella was enlarged in 15 of the 17 patients. The remaining two patients had normal skulls with slight prognathism. Roentgenograms were made of the skeletons of 16 patients, revealing changes in the bone size and of the soft tissues of the hands and feet, typical of acromegaly, in 14 of the patients. Ten patients had had no previous pituitary surgery or roentgen radiation therapy. Six had had previous roentgen therapy: I had a single course of 3500 r, I a single course of 2 000 r, I a single course of 4500 r, I two courses totaling 4 165 r, and another 3 courses totaling 4240 r; one patient had had previous surgical excision of the suprasellar portion of his tumor.
These 17 patients received pituitary alpha-particle irradiation in doses ranging from 4 000 to 9 000 rad given over an interval of II to 21 days. Sixteen of these patients are still living, 13 of them having been treated more than 20 months ago. All but one are known to be feeling well and have resumed their normal work. One patient has signs suggesting temporal lobe invasion and exploration may be necessary. One patient, with long-standing acromegaly, died of cardiomegaly and a coronary occlusion three and a half years after treatment. Two cases of chromophobe adenoma were treated with pituitary irradiation, these patients receiving 4000 to 4500 rad in II days, and both are living 22 and 19 months, respectively, after treatment.
Of the 17 patients, II with acral enlargement showed some improvement following pituitary alpha-particle irradiation. This was primarily a decrease in soft swelling and increase in agility of the fingers and hands. Five patients reported improvement in facial appearance from lessening of soft tissue puffiness. Fifteen had enlarged tongues, and in only 3 of these was there improvement following irradiation. Headache was present in 15 patients before treatment. After treatment II reported improvement, 5 of them stating that they no longer had headaches, the remaining 6 stating that they had occasional or rare headaches of decreased severity. Two patients reported that the head-aches remained the same, and 1 patient had more frequent and more severe headaches 9 months after pituitary irradiation.
The symptom of lethargy and weakness was present in 14 patients before treatment; 9 reported an increase in strength and in tolerance to fatigue. Excessive perspiration, a symptom in 13 patients before treatment, improved in 9. These findings are summarized in Table 2 .
Of the 12 patients questioned regarding libido and impotency, 6 reported a decrease in function prior to pituitary irradiation. Four of these 6 reported subsequent improvement, and 2 no change in sexual function. Of the 5 patients reporting normal function prior to therapy, 4 had no subsequent change, and 1 patient has not yet been re-evaluated.
Fourteen of the 17 acromegalic patients had normal visual fields, fundi, and extra-ocular movements prior to pituitary irradiation. Three of the 14 complained of blurring of vision. After therapy, 2 of these reported no change, and the third stated his vision was '100 per cent better'. Another patient had periorbital swelling and prominent eyes prior to therapy; following treatment there was intermittent improvement in the periorbital swelling and some decrease in the exophthalmos. Three other patients, who had no subjective complaints prior to pituitary irradiation, complained of blurring and difficulty in focusing, which started 13 months after therapy in 2 of them and 1 month after therapy in the third. Another patient with normal visual fields prior to irradiation suddenly developed 'a shade over the upper half of the left eye' 10 months after irradiation. Visual field studies showed a gross defect of the right upper nasal field and a gross defect in the left upper temporal area. This was probably related to the tumor and not to a delayed irradiation effect. Examination 7 months later revealed definite improvement in the patient's fields.
Three patients had objective ophthalmologic findings on initial examination. One of these patients had had a suprasellar extension of his pituitary tumor, with accompanying gross nasal field defect and marked right optic atrophy. The suprasellar portion of the tumor was excised surgically prior to pituitary irradiation. However, the vision in the right eye remained poor 36 months post-irradiation. Another patient had right lateral strabismus due to weak right medial rectus prior to pituitary irradiation. Following therapy, definite improvement in oculomotor capacity was noted, namely, in the ability to fuse and in convergence. The third patient had normal fundi and extraocular movements, but there was a question of possible minimal visual field impairment. Follow-up examination 10 months after treatment revealed no change.
Two patients with chromophobe adenomas had visual field defects as their primary symptoms.
One, a 41-year-old male, had a gross defect in the visual field prior to pituitary irradiation and had undergone surgical decompression followed by marked improvement in VISIOn. Histopathologic investigation showed many anaplastic figures. Three months following treatment there was improvement in visual acuity and visual field studies showed but slight residual field defect. About a year later the patient developed cerebrospinal rhinorrhea and it was decided to re-explore surgically. Recurrence of tumor was observed in the region ofthe anterior sella which extended upward compressing the optic nerve, and this was removed. It was noted that the patient had suffered no visual impairment. The second patient, an 18-year-old boy, had partial right third nerve paralysis and a nasal field defect prior to pituitary irradiation. The months following treatment, visual acuity had increased from 20/200 to 20/20; the left eye remained 20/15. The right nasal field defect disappeared. There was a decrease in the right oculomotor paresis. Eight months later, however, the visual acuity had again dropped to 20/200. The lower nasal quadrant field defect had reappeared, the oculomotor status was again worse. These events followed an episode 2 months earlier, at which time the patient had suffered a night of severe vomiting and awoke in the morning with ptosis of the right eyelid and blurred vision in the right eye. This patient was next seen 15 months post-irradiation, and there was some improvement in his right eye vision and ptosis.
Three acromegalic patients also had a diagnosis of diabetes mellitus. Two of these, who were controlled with insulin prior to pituitary irradiation, were able to discontinue insulin altogether and maintain good control following therapy. The third patient was poorly controlled with DBI prior to pituitary irradiation. Five months following therapy, the disease was controlled with diet alone. However, the patient was not careful about his diet, and 3 months later DBI therapy was again started; the disease has been under good control with this regime.
Four other acromegalic patients (non-diabetic) had abnormal glucose tolerance curves prior to irradiation, which improved subsequently, 2 becoming completely normal. One patient, with a normal curve prior to therapy, had an abnormal curve 2 months later, which has remained abnormal for over 2 1/2 years.
Some preliminary data on growth hormone immuno-assay are given in Table 3 (courtesy of Dr C. H. Li and Dr N. R. Moudgal). In these three pa- tients there was a decrease in the growth hormone content in serum after pituitary irradiation. The urinary estrogens, gonadotropins, l7-ketosteroids, 20,2l-ketols as well as 131 1 thyroid uptake and serum phosphorus values are summarized in Table 4 . Of special interest are the relatively high levels of urinary estrogens in the male acromegalies prior to pituitary irradiation, this being the first observation of this as far as we could determine from the literature, and also a decrease in the total urinary estrogens following pituitary irradiation. There is a similar decrease in the urinary l7-ketosteroids and 20,2l-ketols after pituitary irradiation. The serum phosphorus of 12 patients with elevated values before therapy (4.5 mgj 100 ml or greater) decreased to normal values after therapy.
The changes in l7-ketosteroid values following pituitary irradiation are shown in Fig. 1 , and provides evidence of pituitary suppression. In spite of considerable evidence for pituitary suppression at these dosage levels, there is no evidence of clean-cut decrease in PBI or 131 I thyroid uptake. Most patients have not required replacement therapy. Four, who were taking thyroid prior to pituitary irradiation, continued with this medication, and one of these subsequently required hydrocortisone 21 months after treatment. One patient was started on thyroid replacement 8 months following irradiation and on hydrocortisone 2 months after that. Another patient was started on thyroid 3 years after completion of therapy.
From these preliminary observations on this small group of patients, it seems possible that future work with these and other acromegaly patients may lead to further extension of life and possible adequate control of the condition.
In Fig. 2 an attempt is made to present a comparative picture of the relative amounts of irradiation delivered at various distances from the center of the sella in the 3 axes, x, y, and z. When gOO-MeV alpha particles are compared with 2-MeV roentgen rays and, in both cases, combining the body angulation and head rotation techniques, there is relatively less radiation to the cranial nerves and temporal lobes in the case of the former.
On the basis of our experiences during the past 10 years with alpha-particle pituitary irradiation, when we administered much larger doses to patients with metastatic breast cancer, we do not expect cranial nerve or temporal lobe damage in the present group of patients. Since the latter have received twice the amount of irradiation to the pituitary gland as is usually given for acromegaly, and since this amount probably can be increased safely 50 per cent or much more when the Bragg curve is used, it seems possible that the disease can be controlled satisfactorily by this new method of delivering a high-energy particulate radiation. It is encouraging to know that recently groups at U ppsala (NAESLUND et colI. 1959 , LARSSON 1961 and at Harvard University (KJELL-BERG, PRESTON and SWEET) have adopted these techniques and are extending these investigations. 
SUMMARY

RESUME
Dix-scpt malades atteints cl'acromegalie et deux cl'adenome chromophobe ont ete traites par irradiation de I'hypophyse au moyen de particules alpha de 900 MeV. Apres ce traitement, trois malades qui presentaient en outre un diabcte sucre n'ont plus eu besoin d'insuline. Les hommes acromegalcs avaient avant Ic traitement un taux cl'oestrogenes urinaires relativement elcve, qui diminua par la suite. Les taux de phosphore serique, d'hormone somatotrope serique, de steroides et de gonadotrophine urinaires s'abaissercnt. Dix-huit malades sont encore en vie; un est d eced e de thrombose coronaire trois ans et demi apres Ie traitement. Etant donne que cette methode permet d'administrer a I'hypophyse des doses considerablement plus elevees que par roentgcntherapie ou par gammatherapie, on en espere de meilleurs resultats et une nouvelle prolongation de la survie dans l'acromcgalie.
